A meta-analysis study explores the use of hydrocortisone in very preterm neonates for the prevention of bronchopulmonary dysplasia (BPD) and other adverse outcomes. While hydrocortisone did not reduce BPD, it significantly reduced mortality and showed potential benefits on secondary outcomes.
Send us a text
Hydrocortisone in very preterm neonates for BPD prevention: meta-analysis and effect size modifiers.
De Luca D, Ferraioli S, Watterberg KL, Baud O, Gualano MR.Arch Dis Child Fetal Neonatal Ed. 2024 Jan 17:fetalneonatal-2023-326254. doi: 10.1136/archdischild-2023-326254. Online ahead of print.PMID: 38237961
As always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below.
Enjoy!